Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis-Reference-Cited by-同舟云学术

Pro-atherogenic lipid changes and decreased hepatic LDL receptor expression by tocilizumab in rheumatoid arthritis

Published:2013-07 Issue:1 Volume:229 Page:174-181
ISSN:0021-9150
Container-title:Atherosclerosis
language:en
Short-container-title:Atherosclerosis

Author:

Strang Aart C.,Bisoendial Radjesh J.,Kootte Ruud S.,Schulte Dominik M.,Dallinga-Thie Geesje M.,Levels Johannes H.M.,Kok Marc,Vos Koen,Tas Sander W.,Tietge Uwe J.F.,Müller Nike,Laudes Matthias,Gerlag Danielle M.,Stroes Erik S.G.,Tak Paul P.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference46 articles.

1. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors;del Rincon;Arthritis Rheum,2001

2. Which factors are related to the presence of atherosclerosis in rheumatoid arthritis?;Wallberg-Jonsson;Scand J Rheumatol,2004

3. Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis;Sattar;Circulation,2003

4. The prothrombotic state in rheumatoid arthritis: an additive risk factor for adverse cardiovascular events;Bisoendial;Semin Thromb Hemost,2010

5. Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment;Ristic;Rheumatology (Oxford),2010

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Cardiovascular Risk Factors and Atherosclerosis in Rheumatoid Arthritis;European Journal of Internal Medicine;2024-07

2. The use of biological and targeted synthetic basic anti-inflammatory drugs in elderly patients with rheumatoid arthritis: for or against;Problems of Geroscience;2024-06-30

3. Dynamics of modified cardiovascular risk factors in patients with rheumatoid arthritis on the background of 5-year therapy with an interleukin 6 receptor inhibitor;Rheumatology Science and Practice;2024-03-01

4. Novel perspectives on leptin in osteoarthritis: Focus on aging;Genes & Diseases;2023-11

5. Dyslipidemia in rheumatoid arthritis: the possible mechanisms;Frontiers in Immunology;2023-10-25